Ischemic Stroke (IS) Market Insights and Epidemiology Forecast

1. A Detailed report on Ischemic Stroke (IS) Market Size Analysis, Growth Opportunities, Pipeline Development Activities, and Key Companies Ischemic Stroke (IS) occurs when blood flow through a brain artery is blocked by a clot- a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, the more common of the two, occurs when a clot forms within an artery in the brain. An embolic stroke occurs when a clot or small piece of plaque (fatty deposit) breaks off from elsewhere in the body, such as the heart, and travels through the bloodstream only to become stuck in a narrower vessel in the brain. Almost half of all ischemic strokes are due to large vessel occlusion (LVO). An LVO is the most severe and debilitating type of stroke as the clot occludes major arteries and prevents blood flow to significant portions of the brain. Ischemic stroke is also more common in people who have a family history of stroke or who’ve had past strokes. Men are more likely than women to have an ischemic stroke, while blacks have a higher risk than other races or ethnic groups. Risk also increases with age. DelveInsight’s “Ischemic Stroke (IS) Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Ischemic Stroke (IS), historical and forecasted epidemiology as well as the Ischemic Stroke (IS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key facts of the Ischemic Stroke (IS) Market Report: ● As per the study conducted by Edward C Jauch et. al. 2019, nearly 800,000 people suffer from strokes each year in the United States and 82–92% of these strokes are ischemic

2. ● According to the World Health Organization (WHO), an estimated 15 million individuals worldwide suffer from stroke each year. Of these, 5 million die, and another 5 million are left permanently disabled As per the Stroke Association of UK 2018, Up to 25% of childhood Ischemic strokes are linked to congenital heart disease According to the research, men are at higher risk for Ischemic Stroke than women ● ● Request a sample for the Report: https://www.delveinsight.com/sample-request/ischemic-stroke-market Ischemic Stroke (IS) Symptoms: Symptoms of stroke depend on the severity and location of the stroke in the brain. Some people do not experience any symptoms while others experience may experience only one. The symptoms of Ischemic Stroke include – ● ● ● ● ● Paralysis on one side of the body Dizziness Loss of balance Problems with eyesight Sudden numbness or weakness Ischemic Stroke (IS) Market The dynamics of the Ischemic Stroke (IS) market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as SP-8203, Intravenous, and others during the forecasted period 2019-2032. Learn more by requesting for sample @Ischemic Stroke (IS) Market Landscape Ischemic Stroke (IS) Pipeline Therapies: ● ● ● ● SP-8203 Cerebrolysin Intravenous Alteplase Ischemic Stroke (IS) Pipeline Key Companies: ● ● ● ● Teijin Pharma Ever Neuro Pharma Astellas Pharma GrandPharma Click here to read more about Ischemic Stroke (IS) Market Outlook 2032 Related Reports: Ischemic Stroke (IS) Pipeline

3. "Ischemic Stroke (IS) Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Ischemic Stroke (IS) market. A detailed picture of the Ischemic Stroke (IS) pipeline landscape is provided, which includes the disease overview and Ischemic Stroke (IS) treatment guidelines. Ischemic Stroke (IS) Epidemiology DelveInsight's 'Ischemic Stroke (IS) Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Ischemic Stroke (IS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diagnostic Imaging Equipment Market Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. Invasive Candidiasis Market "DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW. Sialidosis Market DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Filgrastim Biosimilar Insight DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Pain Management Devices Market Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 Latest Reports by DelveInsight NCFB Market | Metastatic Bone Pain Market | Ventricular Hypertrophy Market | Diagnostic Imaging Equipment Market | Invasive Candidiasis Market | Upper Limb Hypertonia Market | Sialidosis Market | Filgrastim Biosimilar Insight | 3D Cardiac Mapping System Market | Acanthamoeba Keratitis Market | Adult Growth Hormone Deficiency Market | Advanced Cancer Pain Management

4. Market | Apheresis Market | Arteriovenous fistula Market | Automated external defibrillators (AEDs) Market | Balloon Catheters Market | Calciphylaxis Market | Cerebral Aneurysm Market | Chronic Idiopathic Urticaria Market For more detailed information about the EULAR 2022 conference, visit: https://www.delveinsight.com/eular-conference/eular-2022 To know more about our Competitive Services, Click here: Pharma Competitive Intelligence https://www.delveinsight.com/consulting/competitive-intelligence-services About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Gaurav Bora Email: info@delveinsight.com City: Albany State: New York Country: United States Website: https://www.delveinsight.com